Resources

The Government is inviting feedback on the proposal to implement a single medicinal cannabis licence under the Narcotic Drugs Act 1967 and other associated reforms to the licence application process.

Our plan for how HPRG will maintain and build its regulatory science capability over the next 5 years.

Example follow-up questions to assist applicants in preparing their medicinal cannabis licence applications.

Guideline to assist licence applicants and holders to assess whether they are fit and proper to hold a licence to cultivate, produce or manufacture medicinal cannabis and products.

Guideline to assist licence applicants and holders in designing and meeting standards required for record keeping and reporting matters related to cultivation, production and manufacture of medicinal cannabis.

Application form for a licence to export narcotic, psychotropic and precursor substances.

Information for applicants who intend to apply for a permit to export narcotic, psychotropic and precursor substances from Australia.

Guidance for completing an import or export licence application for narcotic, psychotropic and precursor substances.

Review of the Narcotic Drugs Act 1967 - Final report authored by Professor John McMillan AO, published on 10 July 2019.

Information on how the Office of Drug Control implements cost recovery for regulatory activities.

A total of 50 submissions were received in response to the public consultation between 22 Feb to 22 March 2019. Read the published submissions.

The 2016 amendments to the ND Act included a requirement in section 26A that the Minister cause a review of the operation of the Act to be undertaken as soon as possible after the second anniversary of the commencement of the 2016 amendments.

The Australian Government is exploring the appropriate mechanism to increase the quantity of kava that may be imported into Australia by incoming passengers for personal use.

Update to guidance on sponsored import and supply of unregistered medicinal cannabis products.

Guidance on export of medicinal cannabis and products.

Policy Circular #03/17

Policy Circular #02/17

Policy Circular #01/17

Application form for permission to import substances under Regulation 5G and 5H of the Customs (Prohibited Imports) Regulations 1956.

Application form for a permit to import drug substances under the Special Access Scheme (SAS) only.

Application form for a pre-export notification (PEN) for a precursor substance.

Application form for a licence to export precursor substances controlled under Regulation 10AB of the Customs (Prohibited Exports) Regulations 1958.

Guidance for completing an application for a licence and permit to import substances under the Special Access Scheme (SAS) only.

Guidance for completing an application for permission to import substances under Regulation 5G and 5H of the Customs (Prohibited Imports) Regulations 1956.

Guidance on holding a precursor export licence and submitting a Pre-Export Notification (PEN) for precursor substances.